Navigation Links
Duke selected to receive multi-million dollar grant for HIV vaccine
Date:7/16/2012

DURHAM, N.C. A large federal grant awarded to Duke University will fund a highly focused program to discover how to induce the precise immune factors needed for effective vaccines against HIV.

Barton Haynes, M.D., will be the Duke director of the seven-year grant for the Duke Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery (CHAVI-ID).

Haynes previously led the original Center for HIV/AIDS Vaccine Immunology (CHAVI) consortium, the grant for which just ended in June 2012.

For its role in the new CHAVI-ID program, Duke will receive $19.9 million for the first year beginning this month, according to the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).

Scripps Research Institute was also selected as a second center to receive CHAVI-ID grant funding.

The CHAVI-ID initiative overall may receive as much as $186 million or more over seven years. Duke may receive more than $139 million in total over the same time period.

"Duke is deeply honored to be selected again, as we now build on all the progress made in the initial CHAVI grant and now focus the effort on design of immunogens capable of preventing HIV transmission and protecting people worldwide," said Victor J. Dzau, M.D., Chancellor for Health Affairs and CEO of Duke University Health System.

NIAID originally established CHAVI in response to recommendations of the Global HIV Vaccine Enterprise, a virtual consortium endorsed by world leaders at a G-8 summit in June 2004.

"We were privileged to have the CHAVI grant over the past seven years, and the work in this consortium helped us understand what needed to be done to make a successful AIDS vaccine," said Haynes, who is also director of the Duke Human Vaccine Institute and the Frederic M. Hanes Professor of Medicine and Immunology. "The CHAVI-Immunogen Discovery grant will be used to learn how to do what we need t
'/>"/>

Contact: Mary Jane Gore
mary.gore@duke.edu
919-660-1309
Duke University Medical Center
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Minneapolis Heart Institute selected to participate in Cardiovascular Cell Therapy Research Network
2. Elsevier selected as new publisher of the American Journal of Geriatric Psychiatry
3. UNCs Saskia Neher selected as 2012 Pew Scholar
4. 22 of Americas most promising scientists selected as Pew Biomedical Scholars
5. 2 NASA visualizations selected for computers graphics showcase
6. In search for a vaccine, IU biologist receives $2.3 million to explore chlamydia genomics
7. WHOI researchers, collaborators receive $1.4 million grant to study life in oceans greatest depths
8. Renowned geneticist R. Rodney Howell receives ACMG Foundation Lifetime Achievement Award
9. UF receives $1 million from Keck Foundation to study mechanisms of inherited disease
10. Gladstone scientist Warner C. Greene receives Washington University School of Medicine Alumni Award
11. Carnegies Wolf B. Frommer receives Bogorad Award for Excellence in Plant Biology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2015)... June 23, 2015  Crossmatch™, a leading ... today announced enhanced functionality of its DigitalPersona ... The enhancements build on the native flexibility ... Altus platform and provide expanded mobile credential ... In today,s environment of increasing cyber-attacks and ...
(Date:6/17/2015)... , and HILDEN, Germany , June 17, ... ; Frankfurt Prime Standard: QIA) today launched new Investigator ® ... forensic laboratories in the United States . ... simultaneously analyze multiple key genomic markers (short tandem repeats or ... Quality Sensor to evaluate the quality of DNA in each ...
(Date:6/16/2015)...  With the increasing number and severity of data ... The recent compromise of Federal employee data from ... within government agencies. HYPR Corp. announced today ... authenticator, has been submitted for testing and approval of ... for tamper proofing. The proliferation of ...
Breaking Biology News(10 mins):Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 2Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 3
... Cruz Mountains two closely related species of mice share a ... lives. The California mouse ( Peromyscus californicus ) is characterized ... maniculatus ) is sexually promiscuous. Researchers at the University ... behavior impact the bacteria hosted by each species as well ...
... trials can be time-consuming, expensive and intrusive, but they ... Space Institute in Tullahoma have developed an invention that ... the virtual world. Called "digital Eye Bank," the ... eyes for researchers to use when testing their inventions. ...
... federal research effort to evaluate freshwater sustainability across the ... can be done to make the best use of ... the effects of climate change over the next 10 ... of Georgia are also part of the project. ...
Cached Biology News:Monogamy and the immune system 2Monogamy and the immune system 3Monogamy and the immune system 4Monogamy and the immune system 5University of Tennessee Space Institute researchers make clinical trials a virtual reality 2NC State leads national effort to evaluate fresh water sustainability in the southern US 2
(Date:6/30/2015)... , June 30, 2015 /PRNewswire/ - Resverlogix Corp. ... common shares of Resverlogix have approved the resolutions ... Capital Limited of 5,600,000 units at a price ... each unit being comprised of one common share ... proceeds of approximately CAD$15 million; and (ii) the ...
(Date:6/30/2015)... NEW YORK , June 30, 2015  Today, Americord ... the U.S., announced Andrew Horne , a partner at ... Advisory Board. Logo - http://photos.prnewswire.com/prnh/20150630/226958LOGO   ... appointment to Americord,s Advisory Board," says Martin Smithmyer , ... experience in his legal career that will assist Americord,s growth ...
(Date:6/30/2015)... ... 30, 2015 , ... The maximum number of shares proposed to be purchased ... shares of unvested restricted stock). On June 29, 2015, the last trading day prior ... reported on the OTCBB was $2.29 per share. , The tender offer will expire ...
(Date:6/30/2015)... 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: ... company focused on the development of autologous cell ... Phase 1/2 clinical trial of RCT-01, being tested ... has been enrolled and their tissue biopsy sent ... is comprised of non-bulbar dermal sheath (NBDS) cells ...
Breaking Biology Technology:Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3Americord Registry Announces Andrew Horne as Advisory Board Member 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 2RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 4
... Biovista Inc. today,announced that BVA-101, its drug targeting ... the MOG-induced Experimental Allergic,Encephalomyelitis (EAE) murine model of ... MS and is aimed at neuroprotection, was shown ... toxic effects in this well,established model of MS. ...
... announced that Merck & Co. Inc. has chosen ... collaboration agreement announced in June 2008 to apply ... novel small molecule leads against several drug targets.By ... a new multi-million member proprietary library of small ...
... manager of Xmark Opportunity Fund, L.P. and Xmark Opportunity Fund, Ltd., sent the following letter to the Board of Directors of Icagen, Inc. ... XMARK OPPORTUNITY PARTNERS, LLC, ... 90 Grove Street, ... 201, ...
Cached Biology Technology:Biovista Inc. Announces Positive Efficacy Results in a Pre-Clinical Trial of its BVA-101 Repositioned Drug for Multiple Sclerosis 2Nuevolution Announces Progress in Its Collaboration With Merck & Co. Inc. 2Xmark Requests That Icagen Oust Its CEO and Pursue Strategic Alternatives, and Calls on Board Members to Resign 2
Mouse monoclonal [3F8 ] to smooth muscle Myosin heavy chain I ( Abpromise for all tested applications). entrezGeneID: 4629 SwissProtID: P35749...
Rabbit polyclonal to pCrosstide (HRP) ( Abpromise for all tested applications)....
IkappaB-alpha (112B2) Mouse mAb...
Human sIL-2R/CD25 ELI-PAIR Kit...
Biology Products: